DOCSLIB.ORG

Reconstitution of the Oocyte Transcriptional Network With

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Reconstitution of the Oocyte Transcriptional Network With 1 Reconstitution of the oocyte transcriptional network with transcription factors 2 3 Nobuhiko Hamazaki*1, Hirohisa Kyogoku2, Hiromitsu Araki3, Fumihito Miura3, Chisako 4 Horikawa1, Norio Hamada1,4, So Shimamoto1, Orie Hikabe1, Kinichi Nakashima1, 5 Tomoya Kitajima2, Takashi Ito3, Harry G Leitch5,6, Katsuhiko Hayashi*1 6 7 1 Department of Developmental Stem Cell Biology, Graduate School of Medical 8 Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. 9 2 Laboratory for Chromosome Segregation, RIKEN Center for Biosystems Dynamics 10 Research, Kobe, Japan. 11 3 Department of Biochemistry, Graduate School of Medical Sciences, Kyushu University, 12 Fukuoka, Japan 13 4 Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, 14 Kyushu University, Fukuoka, Japan 15 5 MRC London Institute of Medical Sciences (LMS), London, UK 16 6 Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, 17 London, UK 18 19 Abstract 20 During female germline development oocytes become a highly specialized cell type, and 21 form a maternal cytoplasmic store of crucial factors during oocyte growth. Oocyte 22 growth is triggered at the primordial-primary follicle transition accompanied with dynamic 23 changes in gene expression1, yet the gene regulatory network underpinning oocyte 24 growth remains elusive. Here we identified a set of transcription factors sufficient to 25 trigger oocyte growth. By dissection of the change in gene expression and functional 26 screening using an in vitro oocyte development system, we identified 8 transcription 27 factors, each of which was essential for the primordial-primary follicle transition. 28 Surprisingly, enforced expression of these transcription factors swiftly converted 29 pluripotent stem cells to oocyte-like cells that were competent for fertilization and 30 subsequent cleavage. These transcription factor-induced oocyte-like cells were formed 31 without PGC specification, epigenetic reprogramming or meiosis, establishing that 32 oocyte growth and lineage-specific de novo DNA methylation is separable from the 33 preceding epigenetic reprogramming in PGCs. This study identifies a core set of 34 transcription factors for orchestrating oocyte growth, and also provides an alternative 35 source of ooplasm, which is a unique material for reproductive biology and medicine. 36 37 Main 38 In mouse germline, primordial germ cells (PGCs) go through a sequential 39 differentiation process beginning with PGC specification, followed by migration to the 40 gonad, epigenetic reprogramming (including genome-wide DNA demethylation)2, fate 41 determination3 and sex determination4. Following sex determination, female PGCs enter 42 meiosis thereby becoming oocytes. Oocytes are arrested in the diplotene stage of 43 meiotic prophase I and most are maintained in primordial follicles. Cytoplasmic 44 expansion is triggered upon activation of primordial follicles. Once oocyte growth is 45 triggered, maternal RNAs and proteins are stored in the cytoplasm5,6. Meiosis resumes 46 in full-grown oocytes, establishing metaphase II (MII) oocytes, and is not completed until 47 after fertilization. 48 Oocyte differentiation therefore entails two key processes: oocyte growth and 49 meiosis. Although concurrent, these two features are separable, as evidenced by a 50 seminal study in which Stra8-knockout mice were shown to develop oocyte-like cells 51 that do not enter meiosis. A number of genes essential for early oocyte growth have 52 been identified, including Figla7, Sohlh18, Sohlh29, Lhx810, Nobox11, Taf4b12,13, Yy114 53 and Tbpl215. Transcriptome analysis using oocytes lacking these genes8,10,15-19 and 54 identification of direct target sequences/genes7,8,20-22 has revealed downstream gene 55 cascades involved in early oocyte growth. In addition, a previous microarray analysis 56 uncovered highly dynamic gene expression changes between postnatal day 2 (P2) 57 oocytes in primordial follicles and P6 oocytes in the primary follicles (Primordial to 58 primary follicle transition: PPT)1. Genes enriched at PPT were involved in protein 59 synthesis and transcription1, suggesting a role in oocyte growth. 60 However, there has been limited further advance towards a comprehensive 61 description and functional dissection of the gene regulatory network specifically 62 orchestrating oocyte growth. Here, we identify a set of transcription factors that 63 comprise the underlying gene regulatory network and validate these findings with 64 functional screening. Furthermore, we successfully reconstitute the network in 65 pluripotent stem cells, thereby generating oocyte-like cells that are competent for 66 fertilization and subsequent cleavage divisions. 67 68 Characterization of PPT in oogenesis 69 To identify the gene regulatory network, we utilized our recently established culture 70 system that recapitulated female germline differentiation using embryonic stem cells 71 (ESCs)23. In this culture system, ESCs are differentiated into PGC-like cells (PGCLCs) 72 and then undergo oogenesis to give rise to MII oocytes in the presence of supporting 73 gonadal somatic cells. Using female germline cells in this culture system and their in 74 vivo counterparts, we mapped the trajectory of the female germline cycle by RNA-seq 75 analysis (Fig. 1a and Extended Data Fig.1a). Principal component analysis (PCA) 76 revealed that a highly dynamic gene expression change occurred in oocytes between in 77 vitro differentiation culture day 11 (IVD.D11) and day 13 (IVD.D13), which corresponded 78 to the period between postnatal day 1 (P1) and P8 in vivo. As previous microarray 79 analysis identified PPT between P2 and P6 oocytes1, we considered the transition 80 between IVD11 and IVD13 to represent PPT in vitro. Oocytes also exhibited a rapid 81 increase in their cytoplasmic and nuclear volumes between IVD11 and IVD13, as 82 observed in cytoplasmic expansion at PPT in vivo24, along with a decrease in their 83 nucleus/cytoplasmic (N/C) ratios (Fig. 1b and c). Notably, the magnitude of gene 84 expression changes in PPT was as large as the transition between MII oocytes and 85 early stage preimplantation embryos, a period known as oocyte-to-embryo transition 86 (OET), during which zygotic genome activation (ZGA) occurs25 (Fig. 1a). 87 During PPT, the upregulated genes included those encoding oocyte-specific 88 structural proteins as previously reported1. However, we also identified genes involved 89 in preimplantation development and DNA methylation of the maternal genome (Fig.1d). 90 In addition, upregulation of a subset of long terminal repeat (LTR) retrotransposon 91 families23 and the decline of the ratio of mean X chromosome transcripts in relation to 92 mean transcripts from the autosomes (X:A ratio)1 were observed at PPT (Extended 93 Data Fig.1b and c). As previous studies have described that growing oocytes use TATA 94 promoters, while ZGA is governed by a reciprocal switch from TATA promoter usage 95 back to GC promoter usage26,27, we hypothesised that the gene expression changes 96 observed during PPT might also be coupled with a change in promoter usage. We found 97 that GC nucleotides were enriched in the promoter region of genes highly transcribed 98 until IVD.D11, whereas AT nucleotides were enriched in that of genes highly transcribed 99 from IVD.D13 (Extended Data Fig. 1d). The AT nucleotides were specifically enriched at 100 20-30 bp upstream from the transcriptional start sites, and included TATA-box motifs 101 (Extended Data Fig. 1e-g). These results demonstrate that promoter usage was shifted 102 from GC promoter to TATA promoter usage upon PPT. 103 104 Functional screening of PPT genes 105 To identify key transctiption factors responsible for PPT, we applied weighted gene 106 co-expression network analysis (WGCNA) to our RNA-seq data and identified 34 107 modules (Extended Data Fig. 2a). Among these modules, we focused on five modules 108 (MEcyan, MEdarkred, MEmagenta, MEwhite and MEpurple) whose genes were 109 specifically expressed around PPT. From these modules, we extracted 27 transcription- 110 related genes that fulfilled the GO term “regulation of transcription, DNA-templated 111 (GO:0006355)” (Fig. 1e), and then investigated the functional requirement of these 112 genes for PPT by loss-of-function analysis using ESCs harboring the Blimp1-mVenus 113 (BV) and Stella-ECFP (SC) reporter genes23 (Extended Data Fig. 2b and c). Of the total 114 26 gene-knockout (KO) ESC lines, 11 differentiated normally beyond IVD13, 8 were 115 arrested between IVD11 and IVD13, and 7 were arrested at an earlier stage than 116 IVD.D3 (Extended Data Fig. 2c-e). Transcriptome analysis of these KO oocytes, except 117 for those arrested before IVD3, revealed that the 8 KO-oocytes (Figla, Sohlh1, Lhx8, 118 Nobox, Stat3, Tbpl2, Dynll1 or Sub1-KO oocytes) were arrested before or around PPT 119 (Fig. 1f). These 8 KO-oocytes did not show the representative features of PPT, such as 120 a decrease in the X/A ratio, propensity for TATA promoter usage and upregulation of 121 specific retrotransposons, with the single exception that Dynll1-KO oocytes showed a 122 decreased X/A ratio (Extended Data Fig. 3a-c). Analysis of reciprocal gene expression 123 in each line of KO-oocytes revealed that the 8 genes had a mutual effect on the 124 expression, and an imputed transcriptional network illustrated that Lhx8, Sohlh1, Nobox, 125 and Tbpl2 formed a core network to which Stat3, Dynll1, Sub1 and Figla were tightly 126 connected (Extended Data Fig. 3d and e). 127 128 PPT induction by transcription factors 129 Next we tested whether these 8 genes (hereinafter PPT8) are sufficient to drive 130 PPT and induce competence for oocyte growth. We overexpressed PPT8 in 131 BVSC“NCh”-ESCs, which consisted of BVSC ESCs with the mCherry gene inserted into 132 the Npm2 locus (Extended Data Fig. 4a). Consistent with evidence that Npm2 is 133 specifically expressed at later oogenesis stages in vivo28 and from IVD.D13 in vitro (Fig. 134 1d), Npm2-mCherry expression became visible in the nucleus of BVSCNCh-ESC- 135 derived oocytes from 15 days of IVD culture (Extended Data Fig.
Load more

Recommended publications
  • Euchromatin Histone Methyltransferase II (EHMT2) Regulates the Expression of Ras-Related GTP Binding C (RRAGC) Protein
    BMB Rep. 2020; 53(11): 576-581 BMB www.bmbreports.org Reports Euchromatin histone methyltransferase II (EHMT2) regulates the expression of ras-related GTP binding C (RRAGC) protein Supyong Hwang1, Soyoung Kim1, Kyungkon Kim1,2,3, Jeonghun Yeom2, Sojung Park1 & Inki Kim1,2,3,* 1Biomedical Research Center, ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505, 2Convergence Medicine Research Center (CREDIT), ASAN Institute for Life Sciences, ASAN Medical Center, Seoul 05505, 3Department of Convergence Medicine, University of Ulsan College of Medicine, Seoul 05505, Korea Dimethylation of the histone H3 protein at lysine residue 9 INTRODUCTION (H3K9) is mediated by euchromatin histone methyltransferase II (EHMT2) and results in transcriptional repression of target Epigenetic modifications are gene regulatory mechanisms that genes. Recently, chemical inhibition of EHMT2 was shown to are independent of changes in DNA sequences (1). This mode induce various physiological outcomes, including endoplasmic of gene regulation can be achieved by means of histone and reticulum stress-associated genes transcription in cancer cells. DNA modifications, such as methylation and acetylation (1). To identify genes that are transcriptionally repressed by EHMT2 Among these, methylation at lysine residues 4 (H3K4) and 36 during apoptosis, and cell stress responses, we screened genes (H3K36) of histone H3 are hallmarks of transcriptional acti- that are upregulated by BIX-01294, a chemical inhibitor of vation, whereas methylation of histone H3 residues at lysines EHMT2. RNA sequencing analyses revealed 77 genes that were 9 (H3K9) and 27 (H3K27) leads to repression (2). Methylation upregulated by BIX-01294 in all four hepatic cell carcinoma of histones is accomplished by histone methyltransferases (HMTs) (HCC) cell lines.
    [Show full text]
  • DNMT1 Gene DNA Methyltransferase 1
    DNMT1 gene DNA methyltransferase 1 Normal Function The DNMT1 gene provides instructions for making an enzyme called DNA methyltransferase 1. This enzyme is involved in DNA methylation, which is the addition of methyl groups, consisting of one carbon atom and three hydrogen atoms, to DNA molecules. In particular, the enzyme helps add methyl groups to DNA building blocks ( nucleotides) called cytosines. DNA methylation is important in many cellular functions. These include determining whether the instructions in a particular segment of DNA are carried out or suppressed ( gene silencing), regulating reactions involving proteins and fats (lipids), and controlling the processing of chemicals that relay signals in the nervous system (neurotransmitters). DNA methyltransferase 1 is active in the adult nervous system. Although its specific function is not well understood, the enzyme may help regulate nerve cell (neuron) maturation and specialization (differentiation), the ability of neurons to move (migrate) and connect with each other, and neuron survival. Health Conditions Related to Genetic Changes Autosomal dominant cerebellar ataxia, deafness, and narcolepsy At least four DNMT1 gene mutations have been identified in people with a nervous system disorder called autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCADN). Features of this disorder include difficulty coordinating movements (ataxia), hearing loss caused by abnormalities of the inner ear (sensorineural deafness), and excessive daytime sleepiness (narcolepsy). Cognitive decline occurs as the disorder progresses. Numbness, tingling, or pain in the arms and legs (sensory neuropathy) can also occur. Affected individuals usually survive into their forties or fifties. The DNMT1 gene mutations associated with this disorder affect a region of the DNA methyltransferase 1 enzyme, known as the targeting sequence, that helps direct the methylation process to the correct segments of DNA.
    [Show full text]
  • Regulation of DNMT1 Stability Through SET7-Mediated Lysine Methylation in Mammalian Cells
    Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells Pierre-Olivier Este` vea,1, Hang Gyeong China,1, Jack Bennera, George R. Feeherya, Mala Samaranayakea, Gregory A. Horwitzb, Steven E. Jacobsenb, and Sriharsa Pradhana,2 aNew England Biolabs Incorporated, 240 County Road, Ipswich, MA 01938; and bHoward Hughes Medical Institute and Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095-1606 Edited by Jasper Rine, University of California, Berkeley, CA, and approved February 10, 2009 (received for review October 15, 2008) Inheritance of epigenetic information encoded by cytosine DNA A D methylation patterns is crucial for mammalian cell survival, in large ET7 S part through the activity of the maintenance DNA methyltrans- : IP: IgG IP IP: DNMT1 449 kDa ferase (DNMT1). Here, we show that SET7, a known histone 159 kDa Anti- methyltransferase, is involved in the regulation of protein stability DNMT1 Anti- of DNMT1. SET7 colocalizes and directly interacts with DNMT1 and DNMT1 Anti- specifically monomethylates Lys-142 of DNMT1. Methylated SET7 DNMT1 peaks during the S and G2 phases of the cell cycle and is DsRed- Merged/ prone to proteasome-mediated degradation. Overexpression of B C Time Nucleus DNMT1 SET7 Merged Nucleus SET7 leads to decreased DNMT1 levels, and siRNA-mediated knock- (hrs) down of SET7 stabilizes DNMT1. These results demonstrate that 2-4 SET7 PRMT1 signaling through SET7 represents a means of DNMT1 enzyme G9a DNMT1 turnover. [3H] 4-8 DNA methyltransferase ͉ methylated lysine ͉ proteasome ͉ protein degradation 8-12 H3 H4 ammalian DNA methylation is essential for development Mand is controlled by a variety of factors including 3 active >15 DNA cytosine methyltransferases (DNMT1, DNMT3A, and DNMT3B) and a methyltransferase-like protein, DNMT3L (1– 4).
    [Show full text]
  • The Rb/Chromatin Connection and Epigenetic Control: Opinion
    Oncogene (2001) 20, 3128 ± 3133 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc The Rb/chromatin connection and epigenetic control: opinion Roger Ferreira1, Irina Naguibneva1, Linda L Pritchard1, Slimane Ait-Si-Ali1 and Annick Harel-Bellan*,1 1Laboratoire `OncogeneÁse, DieÂrenciation et Transduction du Signal', CNRS UPR 9079, Institut Andre Lwo, 7 rue Guy Moquet, Villejuif, France The balance between cell dierentiation and proliferation proteins' family that also includes p130 and p107 (for is regulated at the transcriptional level. In the cell cycle, reviews see Grana et al., 1998; Mulligan and Jacks, the transition from G1 to S phase (G1/S transition) is of 1998). Rb exerts its anti-proliferative activity, at least paramount importance in this regard. Indeed, it is only in part, by inhibiting the E2F transcription factor. Rb before this point that cells can be oriented toward the is regulated by phosphorylation: in non-cycling cells, or dierentiation pathway: beyond, cells progress into the in early G1, Rb is hypophosphorylated and inhibits cycle in an autonomous manner. The G1/S transition is E2F activity; during G1, Rb is progressively phos- orchestrated by the transcription factor E2F. E2F controls phorylated by cyclin-CDK complexes (for review see the expression of a group of checkpoint genes whose Harbour and Dean, 2000) and, as a consequence, loses products are required either for the G1-to-S transition its anity for E2F. The release of Rb triggers the itself or for DNA replication (e.g. DNA polymerase a). activation of E2F target genes, which allows the cells E2F activity is repressed in growth-arrested cells and in to proceed through the G1/S transition.
    [Show full text]
  • Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer
    Published OnlineFirst July 11, 2011; DOI: 10.1158/0008-5472.CAN-10-3823 Cancer Therapeutics, Targets, and Chemical Biology Research Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer Barbara Stefanska1, Jian Huang4, Bishnu Bhattacharyya1, Matthew Suderman1,2, Michael Hallett3, Ze-Guang Han4, and Moshe Szyf1,2 Abstract We use hepatic cellular carcinoma (HCC), one of the most common human cancers, as a model to delineate the landscape of promoter hypomethylation in cancer. Using a combination of methylated DNA immunopre- cipitation and hybridization with comprehensive promoter arrays, we have identified approximately 3,700 promoters that are hypomethylated in tumor samples. The hypomethylated promoters appeared in clusters across the genome suggesting that a high-level organization underlies the epigenomic changes in cancer. In normal liver, most hypomethylated promoters showed an intermediate level of methylation and expression, however, high-CpG dense promoters showed the most profound increase in gene expression. The demethylated genes are mainly involved in cell growth, cell adhesion and communication, signal transduction, mobility, and invasion; functions that are essential for cancer progression and metastasis. The DNA methylation inhibitor, 5- aza-20-deoxycytidine, activated several of the genes that are demethylated and induced in tumors, supporting a causal role for demethylation in activation of these genes. Previous studies suggested that MBD2 was involved in demethylation of specific human breast and prostate cancer genes. Whereas MBD2 depletion in normal liver cells had little or no effect, we found that its depletion in human HCC and adenocarcinoma cells resulted in suppression of cell growth, anchorage-independent growth and invasiveness as well as an increase in promoter methylation and silencing of several of the genes that are hypomethylated in tumors.
    [Show full text]
  • Genetic Mechanisms Underlying the Evolutionary Success of Eusocial Insects
    insects Review (Epi)Genetic Mechanisms Underlying the Evolutionary Success of Eusocial Insects Kayli R. Sieber 1 , Taylor Dorman 1, Nicholas Newell 1 and Hua Yan 1,2,* 1 Department of Biology, University of Florida, Gainesville, FL 32611, USA; kayli.sieber@ufl.edu (K.R.S.); taylor.dorman@ufl.edu (T.D.); nicholas.newell@ufl.edu (N.N.) 2 Center for Smell and Taste, University of Florida, Gainesville, FL 32611, USA * Correspondence: hua.yan@ufl.edu; Tel.: +1-352-273-4983 Simple Summary: Social insects, namely ants, bees, and termites, are among the most numerous and successful animals on Earth. This is due to a variety of features: highly cooperative behavior performed by colony members and their specialization on a variety of tasks. Diverse physiological and behavioral specializations are regulated not only by the genetic system, but also by the epige- netic system which alters gene expressions without modifying the genetic code. This review will summarize recent advancements in such studies in eusocial insects. Abstract: Eusocial insects, such as bees, ants, and wasps of the Hymenoptera and termites of the Blattodea, are able to generate remarkable diversity in morphology and behavior despite being genetically uniform within a colony. Most eusocial insect species display caste structures in which reproductive ability is possessed by a single or a few queens while all other colony members act Citation: Sieber, K.R.; Dorman, T.; as workers. However, in some species, caste structure is somewhat plastic, and individuals may Newell, N.; Yan, H. (Epi)Genetic switch from one caste or behavioral phenotype to another in response to certain environmental cues.
    [Show full text]
  • Selective Epigenetic Alteration of Layer I Gabaergic Neurons Isolated From
    Molecular Psychiatry (2007) 12, 385–397 & 2007 Nature Publishing Group All rights reserved 1359-4184/07 $30.00 www.nature.com/mp ORIGINAL ARTICLE Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection WB Ruzicka, A Zhubi, M Veldic, DR Grayson, E Costa and A Guidotti Department of Psychiatry, College of Medicine, The Psychiatric Institute, University of Illinois at Chicago, Chicago, IL, USA Among the most consistent results of studies of post-mortem brain tissue from schizophrenia patients (SZP) is the finding that in this disease, several genes expressed by GABAergic neurons are downregulated. This downregulation may be caused by hypermethylation of the relevant promoters in affected neurons. Indeed, increased numbers of GABAergic interneurons expressing DNA methyltransferase 1 (DNMT1) mRNA have been demonstrated in the prefrontal cortex (PFC) of SZP using in situ hybridization. The present study expands upon these findings using nested competitive reverse transcription-polymerase chain reaction combined with laser-assisted microdissection to quantitate the extent of DNMT1 mRNA overexpression in distinct populations of GABAergic neurons obtained from either layer I or layer V of the PFC of SZP. In a cohort of eight SZP and eight non-psychiatric subject (NPS) post-mortem BA9 tissue samples, DNMT1 mRNA was found to be selectively expressed in GABAergic interneurons and virtually absent in pyramidal neurons. DNMT1 mRNA expression was approximately threefold higher in GABAergic interneur- ons microdissected from layer I of SZP relative to the same neurons microdissected from NPS. GABAergic interneurons obtained from layer V of the same samples displayed no difference in DNMT1 mRNA expression between groups.
    [Show full text]
  • IL-6 Enhances the Nuclear Translocation of DNA Cytosine-5-Methyltransferase 1 (DNMT1) Via Phosphorylation of the Nuclear Localization Sequence by the AKT Kinase
    CANCER GENOMICS & PROTEOMICS 4: 387-398 (2007) IL-6 Enhances the Nuclear Translocation of DNA Cytosine-5-Methyltransferase 1 (DNMT1) via Phosphorylation of the Nuclear Localization Sequence by the AKT Kinase DAVID R. HODGE1, EDWARD CHO2, TERRY D. COPELAND3, TAD GUSZCZYNSKI3, ERIC YANG4, ARUN K. SETH4 and WILLIAM L. FARRAR1 1Laboratory of Cancer Prevention, Cancer Stem Cell Section, Center for Cancer Research, and 3Laboratory of Protein Dynamics and Signaling, Protein Chemistry Core Facility, The National Cancer Institute at Frederick, Frederick, Maryland, 21702; 2Image Analysis Laboratory, Confocal Microscopy Laboratory, SAIC Frederick, Maryland 21702, USA; 4Laboratory of Molecular Pathology, University of Toronto, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada M4N 3M5 Abstract. The epigenetic programming of genomic DNA is and reveals a potential mechanism for the induction or accomplished, in part, by several DNA cytosine-5- enhancement of tumor growth via alteration of the components methyltransferases that act by covalently modifying cytosines involved in the epigenetic programming of a cell. with the addition of a methyl group. This covalent modification is maintained by the DNA cytosine-5-methyltransferase-1 In the human genome, approximately 4% of the cytosine enzyme (DNMT1), which is capable of acting in concert with residues are found in a covalently modified state resulting other similar enzymes to silence important tumor suppressor from the enzymatic addition of a methyl group at the fifth genes. IL-6 is a multifunctional mediator of inflammation, carbon position (1). DNA methylation is responsible for the acting through several major signaling cascades, including the establishment of the epigenetic "program," which functions to phosphatidylinositol-3-kinase pathway (PI-3-K), which create tissue specific regulation and patterns of gene activates protein kinase B (AKT/PKB) downstream.
    [Show full text]
  • Anxiety Is Associated with Higher Levels of Global DNA Methylation and Altered Expression of Epigenetic and Interleukin-6 Genes Therese M
    Original article 71 Anxiety is associated with higher levels of global DNA methylation and altered expression of epigenetic and interleukin-6 genes Therese M. Murphya, Aoife O’Donovanb, Niamh Mullinsc, Cliona O’Farrellye, Amanda McCannd and Kevin Malonec Objectives Anxiety is associated with elevated levels of Interestingly, IL-6 gene expression was correlated strongly the inflammatory cytokine interleukin-6 (IL-6) and an with DNMT1/3A/3B and EZH2 expression, highlighting increased risk for diseases with an inflammatory aetiology. a potential relationship between IL-6 and important In cancer, higher levels of IL-6 have been associated with epigenetic regulatory enzymes. increased expression of the epigenetic enzymes DNMT1 Conclusion This study provides novel insight into the and Enhancer of Zeste Homolog 2 (EZH2). However, the relationship between anxiety, epigenetics and IL-6. relationship between IL-6 and DNA methyltransferases Moreover, our findings support the hypothesis that changes (DNMTs) and EZH2 expression has not previously been in DNA methylation profiles may contribute to the biology examined in anxious individuals. of anxiety. Psychiatr Genet 25:71–78 Copyright © 2015 Methods Global DNA methylation levels were measured Wolters Kluwer Health, Inc. All rights reserved. using the Methylflash Methylated DNA Quantification Kit Psychiatric Genetics 2015, 25:71–78 and gene expression levels of the DNMT and EZH2 genes in anxious (n = 25) and nonanxious individuals (n = 22) were Keywords: anxiety, DNA methylation, DNA methyltransferase, inflammation, interleukin-6 compared using quantitative real-time PCR. Specifically, we investigated whether global DNA methylation or aberrant aMedical School, University of Exeter, Royal Devon and Exeter Hospital, Exeter, UK, bDepartment of Psychiatry, San Francisco & San Francisco VA Medical expression of these genes was correlated with IL-6 mRNA Center, University of California, USA, cDepartment of Psychiatry and Mental and protein serum levels in anxious individuals.
    [Show full text]
  • EHMT2 Directs DNA Methylation for Efficient Gene Silencing in Mouse Embryos
    Downloaded from genome.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Research EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos Ghislain Auclair,1 Julie Borgel,2,3,4 Lionel A. Sanz,2,3,5 Judith Vallet,1 Sylvain Guibert,1 Michael Dumas,1 Patricia Cavelier,2 Michael Girardot,2 Thierry Forné,2 Robert Feil,2 and Michael Weber1 1CNRS, University of Strasbourg, UMR7242 Biotechnology and Cell Signaling, 67412 Illkirch, France; 2Institute of Molecular Genetics, CNRS UMR5535, University of Montpellier, 34293 Montpellier, France The extent to which histone modifying enzymes contribute to DNA methylation in mammals remains unclear. Previous studies suggested a link between the lysine methyltransferase EHMT2 (also known as G9A and KMT1C) and DNA methyl- ation in the mouse. Here, we used a model of knockout mice to explore the role of EHMT2 in DNA methylation during mouse embryogenesis. The Ehmt2 gene is expressed in epiblast cells but is dispensable for global DNA methylation in embryogenesis. In contrast, EHMT2 regulates DNA methylation at specific sequences that include CpG-rich promoters of germline-specific genes. These loci are bound by EHMT2 in embryonic cells, are marked by H3K9 dimethylation, and have strongly reduced DNA methylation in Ehmt2−/− embryos. EHMT2 also plays a role in the maintenance of germ- line-derived DNA methylation at one imprinted locus, the Slc38a4 gene. Finally, we show that DNA methylation is instru- mental for EHMT2-mediated gene silencing in embryogenesis. Our findings identify EHMT2 as a critical factor that facilitates repressive DNA methylation at specific genomic loci during mammalian development.
    [Show full text]
  • Catalytic Inhibition of H3k9me2 Writers Disturbs Epigenetic Marks
    www.nature.com/scientificreports OPEN Catalytic inhibition of H3K9me2 writers disturbs epigenetic marks during bovine nuclear reprogramming Rafael Vilar Sampaio 1,3,4*, Juliano Rodrigues Sangalli1,4, Tiago Henrique Camara De Bem 1, Dewison Ricardo Ambrizi1, Maite del Collado 1, Alessandra Bridi 1, Ana Clara Faquineli Cavalcante Mendes de Ávila1, Carolina Habermann Macabelli 2, Lilian de Jesus Oliveira1, Juliano Coelho da Silveira 1, Marcos Roberto Chiaratti 2, Felipe Perecin 1, Fabiana Fernandes Bressan1, Lawrence Charles Smith3, Pablo J Ross 4 & Flávio Vieira Meirelles1* Orchestrated events, including extensive changes in epigenetic marks, allow a somatic nucleus to become totipotent after transfer into an oocyte, a process termed nuclear reprogramming. Recently, several strategies have been applied in order to improve reprogramming efciency, mainly focused on removing repressive epigenetic marks such as histone methylation from the somatic nucleus. Herein we used the specifc and non-toxic chemical probe UNC0638 to inhibit the catalytic activity of the histone methyltransferases EHMT1 and EHMT2. Either the donor cell (before reconstruction) or the early embryo was exposed to the probe to assess its efect on developmental rates and epigenetic marks. First, we showed that the treatment of bovine fbroblasts with UNC0638 did mitigate the levels of H3K9me2. Moreover, H3K9me2 levels were decreased in cloned embryos regardless of treating either donor cells or early embryos with UNC0638. Additional epigenetic marks such as H3K9me3, 5mC, and 5hmC were also afected by the UNC0638 treatment. Therefore, the use of UNC0638 did diminish the levels of H3K9me2 and H3K9me3 in SCNT-derived blastocysts, but this was unable to improve their preimplantation development.
    [Show full text]
  • DNA METHYLATION by DNMT1 and Dnmt3b METHYLTRANSFERASES IS DRIVEN by the MUC1-C ONCOPROTEIN in HUMAN CARCINOMA CELLS
    DNA METHYLATION BY DNMT1 AND DNMT3b METHYLTRANSFERASES IS DRIVEN BY THE MUC1-C ONCOPROTEIN IN HUMAN CARCINOMA CELLS The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Rajabi, Hasan, Ashujit Tagde, Maroof Alam, Audrey Bouillez, Sean Pitroda, Yozo Suzuki, and Donald Kufe. 2016. “DNA METHYLATION BY DNMT1 AND DNMT3b METHYLTRANSFERASES IS DRIVEN BY THE MUC1-C ONCOPROTEIN IN HUMAN CARCINOMA CELLS.” Oncogene :10.1038/onc.2016.180. doi:10.1038/onc.2016.180. http:// dx.doi.org/10.1038/onc.2016.180. Published Version doi:10.1038/onc.2016.180 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:29626079 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Oncogene Manuscript Author . Author manuscript; Manuscript Author available in PMC 2016 November 24. DNA METHYLATION BY DNMT1 AND DNMT3b METHYLTRANSFERASES IS DRIVEN BY THE MUC1-C ONCOPROTEIN IN HUMAN CARCINOMA CELLS Hasan Rajabi1, Ashujit Tagde1, Maroof Alam1, Audrey Bouillez1, Sean Pitroda2, Yozo Suzuki1,*, and Donald Kufe1 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 2Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL Abstract Aberrant expression of the DNA methyltransferases (DNMTs) and disruption of DNA methylation patterns are associated with carcinogenesis and cancer cell survival. The oncogenic MUC1-C protein is aberrantly overexpressed in diverse carcinomas; however, there is no known link between MUC1-C and DNA methylation.
    [Show full text]